Cargando…

Discovery of Novel Bromophenol Hybrids as Potential Anticancer Agents through the Ros-Mediated Apoptotic Pathway: Design, Synthesis and Biological Evaluation

A series of bromophenol hybrids with N-containing heterocyclic moieties were designed, and their anticancer activities against a panel of five human cancer cell lines (A549, Bel7402, HepG2, HCT116 and Caco2) using MTT assay in vitro were explored. Among them, thirteen compounds (17a, 17b, 18a, 19a,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li-Jun, Guo, Chuan-Long, Li, Xiang-Qian, Wang, Shuai-Yu, Jiang, Bo, Zhao, Yue, Luo, Jiao, Xu, Kuo, Liu, Hua, Guo, Shu-Ju, Wu, Ning, Shi, Da-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706033/
https://www.ncbi.nlm.nih.gov/pubmed/29104274
http://dx.doi.org/10.3390/md15110343
_version_ 1783282146404728832
author Wang, Li-Jun
Guo, Chuan-Long
Li, Xiang-Qian
Wang, Shuai-Yu
Jiang, Bo
Zhao, Yue
Luo, Jiao
Xu, Kuo
Liu, Hua
Guo, Shu-Ju
Wu, Ning
Shi, Da-Yong
author_facet Wang, Li-Jun
Guo, Chuan-Long
Li, Xiang-Qian
Wang, Shuai-Yu
Jiang, Bo
Zhao, Yue
Luo, Jiao
Xu, Kuo
Liu, Hua
Guo, Shu-Ju
Wu, Ning
Shi, Da-Yong
author_sort Wang, Li-Jun
collection PubMed
description A series of bromophenol hybrids with N-containing heterocyclic moieties were designed, and their anticancer activities against a panel of five human cancer cell lines (A549, Bel7402, HepG2, HCT116 and Caco2) using MTT assay in vitro were explored. Among them, thirteen compounds (17a, 17b, 18a, 19a, 19b, 20a, 20b, 21a, 21b, 22a, 22b, 23a, and 23b) exhibited significant inhibitory activity against the tested cancer cell lines. The structure-activity relationships (SARs) of bromophenol derivatives were discussed. The promising candidate compound 17a could induce cell cycle arrest at G0/G1 phase and induce apoptosis in A549 cells, as well as caused DNA fragmentations, morphological changes and ROS generation by the mechanism studies. Furthermore, compound 17a suppression of Bcl-2 levels (decrease in the expression of the anti-apoptotic proteins Bcl-2 and down-regulation in the expression levels of Bcl-2) in A549 cells were observed, along with activation caspase-3 and PARP, which indicated that compound 17a induced A549 cells apoptosis in vitro through the ROS-mediated apoptotic pathway. These results might be useful for bromophenol derivatives to be explored and developed as novel anticancer drugs.
format Online
Article
Text
id pubmed-5706033
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57060332017-12-04 Discovery of Novel Bromophenol Hybrids as Potential Anticancer Agents through the Ros-Mediated Apoptotic Pathway: Design, Synthesis and Biological Evaluation Wang, Li-Jun Guo, Chuan-Long Li, Xiang-Qian Wang, Shuai-Yu Jiang, Bo Zhao, Yue Luo, Jiao Xu, Kuo Liu, Hua Guo, Shu-Ju Wu, Ning Shi, Da-Yong Mar Drugs Article A series of bromophenol hybrids with N-containing heterocyclic moieties were designed, and their anticancer activities against a panel of five human cancer cell lines (A549, Bel7402, HepG2, HCT116 and Caco2) using MTT assay in vitro were explored. Among them, thirteen compounds (17a, 17b, 18a, 19a, 19b, 20a, 20b, 21a, 21b, 22a, 22b, 23a, and 23b) exhibited significant inhibitory activity against the tested cancer cell lines. The structure-activity relationships (SARs) of bromophenol derivatives were discussed. The promising candidate compound 17a could induce cell cycle arrest at G0/G1 phase and induce apoptosis in A549 cells, as well as caused DNA fragmentations, morphological changes and ROS generation by the mechanism studies. Furthermore, compound 17a suppression of Bcl-2 levels (decrease in the expression of the anti-apoptotic proteins Bcl-2 and down-regulation in the expression levels of Bcl-2) in A549 cells were observed, along with activation caspase-3 and PARP, which indicated that compound 17a induced A549 cells apoptosis in vitro through the ROS-mediated apoptotic pathway. These results might be useful for bromophenol derivatives to be explored and developed as novel anticancer drugs. MDPI 2017-11-01 /pmc/articles/PMC5706033/ /pubmed/29104274 http://dx.doi.org/10.3390/md15110343 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Li-Jun
Guo, Chuan-Long
Li, Xiang-Qian
Wang, Shuai-Yu
Jiang, Bo
Zhao, Yue
Luo, Jiao
Xu, Kuo
Liu, Hua
Guo, Shu-Ju
Wu, Ning
Shi, Da-Yong
Discovery of Novel Bromophenol Hybrids as Potential Anticancer Agents through the Ros-Mediated Apoptotic Pathway: Design, Synthesis and Biological Evaluation
title Discovery of Novel Bromophenol Hybrids as Potential Anticancer Agents through the Ros-Mediated Apoptotic Pathway: Design, Synthesis and Biological Evaluation
title_full Discovery of Novel Bromophenol Hybrids as Potential Anticancer Agents through the Ros-Mediated Apoptotic Pathway: Design, Synthesis and Biological Evaluation
title_fullStr Discovery of Novel Bromophenol Hybrids as Potential Anticancer Agents through the Ros-Mediated Apoptotic Pathway: Design, Synthesis and Biological Evaluation
title_full_unstemmed Discovery of Novel Bromophenol Hybrids as Potential Anticancer Agents through the Ros-Mediated Apoptotic Pathway: Design, Synthesis and Biological Evaluation
title_short Discovery of Novel Bromophenol Hybrids as Potential Anticancer Agents through the Ros-Mediated Apoptotic Pathway: Design, Synthesis and Biological Evaluation
title_sort discovery of novel bromophenol hybrids as potential anticancer agents through the ros-mediated apoptotic pathway: design, synthesis and biological evaluation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706033/
https://www.ncbi.nlm.nih.gov/pubmed/29104274
http://dx.doi.org/10.3390/md15110343
work_keys_str_mv AT wanglijun discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation
AT guochuanlong discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation
AT lixiangqian discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation
AT wangshuaiyu discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation
AT jiangbo discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation
AT zhaoyue discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation
AT luojiao discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation
AT xukuo discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation
AT liuhua discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation
AT guoshuju discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation
AT wuning discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation
AT shidayong discoveryofnovelbromophenolhybridsaspotentialanticanceragentsthroughtherosmediatedapoptoticpathwaydesignsynthesisandbiologicalevaluation